Appointment of Registering Authority (NOTIFICATIONS)
Appointment of Registering Authority
Appointment of Registering Authority (NOTIFICATIONS) Read More »
DCGI directs drugs manufacturers to file safety & efficacy data on non-approved FDC formulation before 31st August 2013 (NOTIFICATIONS)
DCGI directs drugs manufacturers to file safety & efficacy data on non-approved FDC formulation before 31st August 2013
Immediate withdrawal of the permission to manufacture all combinations of Tapentadol and all combinations of Caresoprodol (CIRCULARS)
Immediate withdrawal of the permission to manufacture all combinations of Tapentadol and all combinations of Caresoprodol
Gastro Resistant Tablets or Capsules, Delayed Release Tablets or Capsules as New Drugs as per Rule 2, (1) (w) of the New Drugs and Clinical Trials Rules, 2019 (CIRCULARS)
Gastro Resistant Tablets or Capsules, Delayed Release Tablets or Capsules as New Drugs as per Rule 2, (1)(w) of the New Drugs and Clinical Trials Rules, 2019
Evaluation of certain pre 1988 permitted Fixed Dose Combinations (FDCs) de novo for manufacture for sale in the country wiithout due approval from Central Licensing Authority (CIRCULARS)
Evaluation of certain pre 1988 permitted Fixed Dose Combinations (FDCs) de novo for manufacture for sale in the country wiithout due approval from Central Licensing Authority
Upload GSR 1230 (E) Dated: 21/12/2018 (NOTIFICATIONS)
Upload GSR 1230 (E) Dated: 21/12/2018
Upload GSR 1230 (E) Dated: 21/12/2018 (NOTIFICATIONS) Read More »
Notification G.S.R. 669 (E) Dated: 28/10/2024 (NOTIFICATIONS)
Notification G.S.R. 669 (E) Dated: 28/10/2024
Notification G.S.R. 669 (E) Dated: 28/10/2024 (NOTIFICATIONS) Read More »
Official Gazette Government of Goa OM 13-09-2023-I PHD dated17.02.2025 (NOTIFICATIONS)
Official Gazette Government of Goa OM 13-09-2023-I PHD dated17.02.2025
Official Gazette Government of Goa OM 13-09-2023-I PHD dated17.02.2025 (NOTIFICATIONS) Read More »
Ease of Doing Business
Wholesale Drug License Licence for Manufacturing Pharmaceutical Prolducts Retail Drug License
Ease of Doing Business Read More »
SO 5663(E) -Nimesulide and its Formulations Prohibited for Animal Use (NOTIFICATIONS)
SO 5663(E) -Nimesulide and its Formulations Prohibited for Animal Use
SO 5663(E) -Nimesulide and its Formulations Prohibited for Animal Use (NOTIFICATIONS) Read More »